|
Access Pharmaceuticals, Inc.'s photostream |
|
Prodrax: Targeting ability
The targeting ability of a Prodrax compound is illustrated here. By using a staining technique, the...
All rights reserved
Uploaded on Aug 13, 2009
David P. Notwotnik, Ph.D., Senior Vice President Research and Development
Bio: * Senior Director, Product Development, Guilford Pharmaceuticals, Inc. * Group Leader,...
All rights reserved
Uploaded on Aug 12, 2009
Stephen B. Thompson, Chief Financial Officer
Bio: * Controller and Administration Manager, API * Controller, Robert E. Woolley, Inc., a hotel...
All rights reserved
Uploaded on Aug 12, 2009
Jeffrey B. Davis, Chief Executive Officer
Bio: * President, SCO Financial Group LLC. * Senior Vice President and Chief Financial Officer...
All rights reserved
Uploaded on Aug 12, 2009
MuGard: OMAS vs. Time
Displays the average mucositis score (OMAS scale; 0=no mucositis, 5=severe mucositis) for patients...
All rights reserved
Uploaded on Aug 12, 2009
ProLindac: Typical results in a mouse tumor model
Typical results for ProLindac in a mouse tumor model; in this case the B16 melanoma model. These...
All rights reserved
Uploaded on Aug 12, 2009
Cobalamin: Mechanism of absorption 1
Our scientists have found that the attachment of Cobalamin™ to drugs, polymers containing drugs, and...
All rights reserved
Uploaded on Aug 12, 2009
Angiolix: Binding
Angiolix is a monoclonal antibody which interrupts VEGF-mediated angiogenesis in tumors; a process...
All rights reserved
Uploaded on Aug 12, 2009
Alchemix: Structure
Access' proprietary Alchemix project is based upon small molecule cytotoxic compounds that can...
All rights reserved
Uploaded on Aug 12, 2009
Thiarabine: Structure
Thiarabine is 4'-thio-beta-D-arabinofuranosylc ytosine (4'-thio-ara-C). This molecule was developed...
All rights reserved
Uploaded on Aug 12, 2009
Pexiganan
Magainins are a family of host defence peptides with broad-spectrum antimicrobial activity that have...
All rights reserved
Uploaded on Aug 12, 2009
MuGard: Pack Shot (SpePharm)
MuGard: Patient Severity
One of the most striking features of a comparison of MuGard to standard of care is that 43% of...
All rights reserved
Uploaded on Aug 12, 2009
Cobalamin: Mechanism of Absorption 2
The Access technology addresses the problem of poor intestinal absorption by utilizing the body's...
All rights reserved
Uploaded on Aug 12, 2009
